(Q80532314)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350531%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

The epithelial-mesenchymal transition of colon carcinoma involves expression of IL-8 and CXCR-1-mediated chemotaxis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350531%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

1 reference

Richard C Bates

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350531%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Michael J DeLeo

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350531%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Arthur M Mercurio

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350531%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

language of work or name

English

0 references

publication date

1 October 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350531%20AND%20SRC:MED&resulttype=core&format=json

Experimental Cell Research

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350531%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

299

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350531%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350531%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

315-324

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350531%20AND%20SRC:MED&resulttype=core&format=json

Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition.

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Epithelial-mesenchymal transitions in tumour progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Epithelial mesenchymal interactions in cancer and development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Flt-1-Dependent Survival Characterizes the Epithelial-Mesenchymal Transition of Colonic Organoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Interleukin-8 receptor-mediated chemotaxis of normal human epidermal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Structure and Functional Expression of a Human Interleukin-8 Receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Cloning of complementary DNA encoding a functional human interleukin-8 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Interleukin‐8 secreted by endothelial cells induces Chemotaxis of melanoma cells through the chemokine receptor CXCR1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Mucosal expression of interleukin-6 and interleukin-8 messenger RNA in ulcerative colitis and in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Distribution of the interleukin-8 receptors, CXCR1 and CXCR2, in inflamed gut tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Interleukin 8 and vascular endothelial growth factor -- prognostic factors in human gastric carcinomas?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Apoptosis induced by inhibition of intercellular contact

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Tumor necrosis factor receptor and Fas signaling mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Cooperation between SMAD and NF-kappaB in growth factor regulated type VII collagen gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Inhibition of E-selectin gene expression by transforming growth factor beta in endothelial cells involves coactivator integration of Smad and nuclear factor kappaB-mediated signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Tumor necrosis factor: biology and therapeutic inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Tumor-associated macrophage infiltration in pulmonary adenocarcinoma: association with angiogenesis and poor prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Antibodies against the N-terminus of IL-8 receptor A inhibit neutrophil chemotaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Regulation of Human Interleukin-8 Receptor A: Identification of a Phosphorylation Site Involved in Modulating Receptor Functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Ligand-induced desensitization of the human CXC chemokine receptor-2 is modulated by multiple serine residues in the carboxyl-terminal domain of the receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Differential modes of regulation of cxc chemokine-induced internalization and recycling of human CXCR1 and CXCR2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

Actin filaments are involved in the regulation of trafficking of two closely related chemokine receptors, CXCR1 and CXCR2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

The CXC Chemokines Growth-regulated Oncogene (GRO) α, GROβ, GROγ, Neutrophil-activating Peptide-2, and Epithelial Cell-derived Neutrophil-activating Peptide-78 Are Potent Agonists for the Type B, but Not the Type A, Human Interleukin-8 Receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2004.05.033

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEXCR.2004.05.033

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15350531%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference